Pre-treatment YKL-40 levels were significantly correlated with FIGO stage and with relapse or persistent disease status, while correlations with nodal status and tumor size were marginal in cervical adenocarcinoma. The gene discussed is CHI3L1; the disease is cervical adenocarcinoma.